331 related articles for article (PubMed ID: 17111148)
21. Adjunctive plaque radiotherapy after local resection of uveal melanoma.
Damato B
Front Radiat Ther Oncol; 1997; 30():123-32. PubMed ID: 9205892
[No Abstract] [Full Text] [Related]
22. Ruthenium-106 plaque brachytherapy for thick posterior uveal melanomas.
Kaiserman N; Kaiserman I; Hendler K; Frenkel S; Pe'er J
Br J Ophthalmol; 2009 Sep; 93(9):1167-71. PubMed ID: 19570767
[TBL] [Abstract][Full Text] [Related]
23. [Surgical management of ciliary body melanoma].
Romanowska-Dixon B
Klin Oczna; 2005; 107(10-12):627-31. PubMed ID: 16619806
[TBL] [Abstract][Full Text] [Related]
24. Long term visual outcome of radiated uveal melanomas in eyes eligible for randomisation to enucleation versus brachytherapy.
Char DH; Kroll S; Quivey JM; Castro J
Br J Ophthalmol; 1996 Feb; 80(2):117-24. PubMed ID: 8814740
[TBL] [Abstract][Full Text] [Related]
25. Long-term visual acuity outcomes in patients with uveal melanoma treated with 125I episcleral OSU-Nag plaque brachytherapy.
Wisely CE; Hadziahmetovic M; Reem RE; Hade EM; Nag S; Davidorf FH; Martin D; Cebulla CM
Brachytherapy; 2016; 15(1):12-22. PubMed ID: 26525215
[TBL] [Abstract][Full Text] [Related]
26. (106)Ru plaque brachytherapy for uveal melanoma: factors associated with local tumor recurrence.
Barker CA; Francis JH; Cohen GN; Marr BP; Wolden SL; McCormick B; Abramson DH
Brachytherapy; 2014; 13(6):584-90. PubMed ID: 24880583
[TBL] [Abstract][Full Text] [Related]
27. Iodine 125 brachytherapy with vitrectomy and silicone oil in the treatment of uveal melanoma: 1-to-1 matched case-control series.
McCannel TA; McCannel CA
Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):347-52. PubMed ID: 24721588
[TBL] [Abstract][Full Text] [Related]
28. Intravitreal triamcinolone versus intravitreal bevacizumab in the treatment of exudative retinal detachment secondary to posterior uveal melanoma.
Parrozzani R; Pilotto E; Dario A; Miglionico G; Midena E
Am J Ophthalmol; 2013 Jan; 155(1):127-133.e2. PubMed ID: 22995029
[TBL] [Abstract][Full Text] [Related]
29. [Results of Iodine-125 radiotherapy in the treatment of uveal melanoma].
Caminal Mitjana JM; Quintana Casany M; Pera Fábregas J; Cinos Cope C; Guedea F
Arch Soc Esp Oftalmol; 2002 Jan; 77(1):29-38. PubMed ID: 11813118
[TBL] [Abstract][Full Text] [Related]
30. Outcomes of cataract surgery in eyes with ocular melanoma treated with iodine-125 brachytherapy.
Bozkurt TK; Tang Q; Grunstein LL; McCannel TA; Straatsma BR; Miller KM
J Cataract Refract Surg; 2018 Mar; 44(3):287-294. PubMed ID: 29703285
[TBL] [Abstract][Full Text] [Related]
31. Plaque radiotherapy for large posterior uveal melanomas (> or =8-mm thick) in 354 consecutive patients.
Shields CL; Naseripour M; Cater J; Shields JA; Demirci H; Youseff A; Freire J
Ophthalmology; 2002 Oct; 109(10):1838-49. PubMed ID: 12359604
[TBL] [Abstract][Full Text] [Related]
32. Collaborative ocular melanoma study (COMS) randomized trial of I-125 brachytherapy for medium choroidal melanoma. I. Visual acuity after 3 years COMS report no. 16.
Melia BM; Abramson DH; Albert DM; Boldt HC; Earle JD; Hanson WF; Montague P; Moy CS; Schachat AP; Simpson ER; Straatsma BR; Vine AK; Weingeist TA;
Ophthalmology; 2001 Feb; 108(2):348-66. PubMed ID: 11158813
[TBL] [Abstract][Full Text] [Related]
33. [Late complications after brachytherapy of I-125 uveal melanoma].
Kowal J; Romanowska-Dixon B
Klin Oczna; 2016; 118(3):226-30. PubMed ID: 30088387
[TBL] [Abstract][Full Text] [Related]
34. Tumor parameters predict the risk of side effects after ruthenium-106 plaque brachytherapy of uveal melanomas.
Tarmann L; Wackernagel W; Ivastinovic D; Schneider M; Winkler P; Langmann G
PLoS One; 2017; 12(8):e0183833. PubMed ID: 28859118
[TBL] [Abstract][Full Text] [Related]
35. Endoresection versus iodine-125 plaque brachytherapy for the treatment of choroidal melanoma.
Caminal JM; Mejia K; Masuet-Aumatell C; Arias L; Piulats JM; Gutierrez C; Pera J; Catala J; Rubio M; Arruga J
Am J Ophthalmol; 2013 Aug; 156(2):334-342.e1. PubMed ID: 23677135
[TBL] [Abstract][Full Text] [Related]
36. Trans-scleral local resection of toxic choroidal melanoma after proton beam radiotherapy.
Konstantinidis L; Groenewald C; Coupland SE; Damato B
Br J Ophthalmol; 2014 Jun; 98(6):775-9. PubMed ID: 24568869
[TBL] [Abstract][Full Text] [Related]
37. Plaque radiotherapy for residual or recurrent iris melanoma after surgical resection in 32 cases.
Shah SU; Shields CL; Bianciotto C; Emrich J; Komarnicky L; Shields JA
Ophthalmology; 2012 Apr; 119(4):838-842.e2. PubMed ID: 22133794
[TBL] [Abstract][Full Text] [Related]
38. Outcomes of choroidal melanomas treated with eye physics: a 20-year review.
Berry JL; Dandapani SV; Stevanovic M; Lee TC; Astrahan M; Murphree AL; Kim JW
JAMA Ophthalmol; 2013 Nov; 131(11):1435-42. PubMed ID: 24008431
[TBL] [Abstract][Full Text] [Related]
39. Endoresection with adjuvant ruthenium brachytherapy for selected uveal melanoma patients - the Tuebingen experience.
Süsskind D; Dürr C; Paulsen F; Kaulich T; Bartz-Schmidt KU
Acta Ophthalmol; 2017 Dec; 95(8):e727-e733. PubMed ID: 27914117
[TBL] [Abstract][Full Text] [Related]
40. Comparison of iodine-125 plaque brachytherapy and gamma knife stereotactic radiosurgery treatment outcomes for uveal melanoma patients.
Guleser UY; Sarici AM; Ucar D; Gonen B; Sengul Samanci N; Özgüroğlu M
Graefes Arch Clin Exp Ophthalmol; 2022 Apr; 260(4):1337-1343. PubMed ID: 34735632
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
